journal article·2024-08-23Open access

Insights into the Dual Anticancer and Antibacterial Activities of Composites Based on Silver Camphorimine Complexes

Joana P. Costa, Sílvia A. Sousa, Jorge H. Leitão, Fernanda Marques, Marta M. Alves, M. Fernanda N. N. Carvalho

Abstract

Hydroxyapatite (HAp) is a widely used biocompatible material in orthopedic composite preparations. However, HAp composites that exhibit both anticancer and antibacterial activities through bioactive coordination complexes are relatively rare. To explore orthopedic applications, we blended several silver camphorimine compounds with HAp to create [Ag(I)] composites. All compounds [Ag(NO3)(L)n] (n = 1,2) based on camphorimine (LA), camphor sulfonimine (LB) or imine bi-camphor (LC) ligands demonstrated significant cytotoxic activity (IC50 = 0.30–2.6 μgAg/mL) against osteosarcoma cancer cells (HOS). Based on their structural and electronic characteristics, four complexes (1–4) were selected for antibacterial evaluation against Escherichia coli, Burkholderia contaminans, Pseudomonas aeruginosa, and Staphylococcus aureus. All complexes (1–4) revealed combined anticancer and antibacterial activities; therefore, they were used to prepare [Ag(I)]:HAp composites of 50:50% and 20:80% weight compositions and the activities of the composites were assessed. Results showed that they retain the dual anticancer and antibacterial characteristics of their precursor complexes. To replicate the clinical context of bone-filling applications, hand-pressed surfaces (pellets) were prepared. It is worth highlighting that no agglutination agent was necessary for the pellet’s consistency. The biological properties of the so-prepared pellets were assessed, and the HOS cells and bacteria spreading on the pellet’s surface were analyzed by SEM. Notably, composite 4B, derived from the bicamphor (LC) complex [Ag(NO3)(OC10H14N(C6H4)2NC10H14O)], exhibited significant anticancer activity against HOS cells and antibacterial activity against P. aeruginosa, fostering potential clinical applications on post-surgical OS treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Metal complexes synthesis and properties · Nanocluster Synthesis and Applications · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centro de Química Estrutural, Institute of Molecular Sciences and Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Avenida António José de Almeida, n.º 12, 1000-043 Lisboa, Portugal

iBB-Institute for Bioengineering and Biosciences, Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Avenida António José de Almeida, n.º 12, 1000-043 Lisboa, Portugal

C2TN-Centro de Ciências e Tecnologias Nucleares and Departamento de Engenharia e Ciências Nucleares, Instituto Superior Técnico, Universidade de Lisboa, EN 10, km 139.7, Bobadela, 2695-066 Loures, Portugal

Funding

Fundação para a Ciência e a Tecnologia—FCT · Associate Laboratory Institute of Molecular Sciences · C2TN · Institute for Bioengineering and Biosciences · Associate Laboratory Institute for Health and Bioeconomy-i4HB

References (59)

Show source-provided references
1. Zhao, X., Wu, Q., Gong, X., Liu, J., and Ma, Y. (2021). Osteosarcoma: A review of current and future therapeutic approaches. Biomed. Eng. Online, 20.10.1186/s12938-021-00860-0 ↗
2. Infectious complications in children with malignant bone tumors: A multicenter nationwide study10.2147/IDR.S199657 ↗
3. Current and future therapeutic approaches for osteosarcoma10.1080/14737140.2018.1413939 ↗
4. Michalakis, K., Bakopoulou, A., Papachristou, E., Vasilaki, D., Tsouknidas, A., Michailidis, N., and Johnstone, E. (2021). Evaluation of the Response of HOS and Saos-2 Osteosarcoma Cell Lines When Exposed to Different Sizes and Concentrations of Silver Nanoparticles. BioMed Res. Int., 2021.10.1155/2021/5013065 ↗
5. Biological reconstruction in the treatment of extremity sarcoma in femur, tibia, and humerus10.1097/MD.0000000000020715 ↗
6. Anagnostakos, K., and Schröder, K. (2012). Antibiotic-Impregnated Bone Grafts in Orthopaedic and Trauma Surgery: A Systematic Review of the Literature. Int. J. Biomater., 2012.10.1155/2012/538061 ↗
7. Shi, H., Zhou, Z., Li, W., Fan, Y., Li, Z., and Wei, J. (2021). Hydroxyapatite Based Materials for Bone Tissue Engineering: A Brief and Comprehensive Introduction. Crystals, 11.10.3390/cryst11020149 ↗
8. Silver@Hydroxyapatite functionalized calcium carbonate composites: Characterization, antibacterial and antibiofilm activities and cytotoxicity10.1016/j.apsusc.2022.152760 ↗
9. Multifunctional Hydroxyapatite Composites for Orthopedic Applications: A Review10.1021/acsbiomaterials.2c00140 ↗
10. Mo, X., Zhang, D., Liu, K., Zhao, X., Li, X., and Wang, W. (2023). Nano-Hydroxyapatite Composite Scaffolds Loaded with Bioactive Factors and Drugs for Bone Tissue Engineering. Int. J. Mol. Sci., 24.10.3390/ijms24021291 ↗
11. Olajide, J.L., Desai, D.A., Ajibola, J.O., Adekoya, G.J., Daramola, O.O., Alaneme, K.K., Fasiku, V.O., and Sadiku, E.R. (2020). Nosocomial Bacterial Infection of Orthopedic Implants and Antibiotic Hydroxyapatite/Silver-Coated Halloysite Nanotube With Improved Structural Integrity as Potential Prophylaxis. Antibiotic Materials in Health Care, Elsevier Inc.. Chapter 11.10.1016/B978-0-12-820054-4.00011-2 ↗
12. Advanced surface treatment techniques counteract biofilm associated infections on dental implant10.1088/2053-1591/ab6a57 ↗
13. Rodríguez-Merchán, E.C., Davidson, D.J., and Liddle, A.D. (2021). Recent Strategies to Combat Infections from Biofilm-Forming Bacteria on Orthopaedic Implants. Int. J. Mol. Sci., 22.10.3390/ijms221910243 ↗
14. A review on antimicrobial strategies in mitigating biofilm-associated infections on medical implants
15. A smart coating with integrated physical antimicrobial and strain-mapping functionalities for orthopedic implants10.1126/sciadv.adg7397 ↗
16. Odri, G.A., Tchicaya-Bouanga, J., Yoon, D.J.Y., and Modrowski, D. (2022). Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers. Cancers, 14.10.3390/cancers14020360 ↗
17. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM–PLGA microspheres for bone cancer treatment10.1007/s10856-016-5699-0 ↗
18. Korbut, A., Włodarczyk, M., Rudnicka, K., Szwed, A., Płociński, P., Biernat, M., Tymowicz-Grzyb, P., Michalska, M., Karska, N., and Rodziewicz-Motowidło, S. (2021). Three Component Composite Scaffolds Based on PCL, Hydroxyapatite, and L-Lysine Obtained in TIPS-SL: Bioactive Material for Bone Tissue Engineering. Int. J. Mol. Sci., 22.10.3390/ijms222413589 ↗
19. Kumar, A., Kargozar, S., Baino, F., and Han, S.S. (2019). Additive Manufacturing Methods for Producing Hydroxyapatite and Hydroxyapatite-Based Composite Scaffolds: A Review. Front. Mater. Sec. Biomater., 6.10.3389/fmats.2019.00313 ↗
20. Al-Shalawi, F.D., Ariff, A.H.M., Jung, D.-W., Ariffin, M.K.A.M., Kim, C.L.S., Brabazon, D., and Al-Osaimi, M.O. (2023). Biomaterials as Implants in the Orthopedic Field for Regenerative Medicine: Metal versus Synthetic Polymers. Polymers, 15.10.3390/polym15122601 ↗
21. Investigation on bioactivity and cytotoxicity of mesoporous nano-composite MCM-48/hydroxyapatite for ibuprofen drug delivery10.1016/j.ceramint.2013.12.079 ↗
22. Mitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicin10.1016/j.biomaterials.2016.04.004 ↗
23. Fabrication of novel Si-doped hydroxyapatite/gelatine scaffolds by rapid prototyping for drug delivery and bone regeneration
24. Hydroxyapatite–polymer biocomposites for bone regeneration: A review of current trends10.1002/jbm.b.33950 ↗
25. Fraile-Martínez, O., García-Montero, C., Coca, A., Álvarez-Mon, M.A., Monserrat, J., Gómez-Lahoz, A.M., Coca, S., Álvarez-Mon, M., Acero, J., and Bujan, J. (2021). Applications of Polymeric Composites in Bone Tissue Engineering and Jawbone Regeneration. Polymers, 13.10.3390/polym13193429 ↗
26. Silver Oxide-Containing Hydroxyapatite Coating Has In vivo Antibacterial Activity in the Rat Tibia10.1002/jor.22357 ↗
27. Ahmaruzzaman, Hydroxyapatite-based composites: Excellent materials for environmental remediation and biomedical applications10.1016/j.cis.2023.102890 ↗
28. Boanini, E., Cassani, M.C., Rubini, K., Boga, C., and Bigi, A. (2018). (9R)-9-Hydroxystearate-Funcionalized Anticancer Ceramics Promote Loading of Silver Nanoparticles. Nanomaterials, 8.10.3390/nano8060390 ↗
29. Bioactive silver doped hydroxyapatite composite coatings on metal substrates: Synthesis and characterization10.1016/j.matchemphys.2018.07.038 ↗
30. Functionalized Porous Hydroxyapatite Scaffolds for Tissue Engineering Applications: A Focused Review10.1021/acsbiomaterials.1c00438 ↗
31. Functionalization of the hydroxyapatite surface with ZnO for alizarin immobilization
32. Advances in drug delivery and biomedical applications of hydroxyapatite-based systems: A review10.1007/s12034-022-02758-6 ↗
33. Marcello, E., Maqbool, M., Nigmatullin, R., Cresswell, M., Jackson, P.R., Basnett, P., Knowles, J.C., Boccaccini, A.R., and Roy, I. (2021). Antibacterial composite materials based on the combination of polyhydroxyalkanoates with selenium and strontium co-substituted hydroxyapatite for bone regeneration. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.647007 ↗
34. Multifunctional magnetic ZnFe2O4-hydroxyapatite nanocomposite particles for local anti-cancer drug delivery and bacterial infection inhibition: An in vitro study10.1016/j.jtice.2018.10.018 ↗
35. Lotlikar, S.R., Gallaway, E., Grant, T., Popis, S., Whited, M., Guragain, M., Rogers, R., Hamilton, S., Gerasimchuk, N.G., and Patrauchan, M.A. (2019). Polymeric Composites with Silver (I) cyanoximates Inhibit Biofilm Formation of Gram-Positive and Gram-Negative Bacteria. Polymers, 11.10.3390/polym11061018 ↗
36. Leitão, J.H., Sousa, S.A., Leite, S.A., and Carvalho, M.F.N. (2018). Silver camphorimine complexes: Novel antibacterial compounds from old medicines. Antibiotics, 7.10.3390/antibiotics7030065 ↗
37. Synthesis and assessment of the cytotoxic and DNA binding properties of Ag(I) camphor sulphonylimine complexes10.1016/j.jinorgbio.2016.11.003 ↗
38. Costa, J.P., Pinheiro, T., Martins, M.S., Carvalho, M.F.N.N., Feliciano, J.R., Leitão, J.H., Silva, R.A.L., Guerreiro, J.F., Alves, L.M.C., and Custódio, I. (2022). Tuning the Biological Activity of Camphorimine Complexes through Metal Selection. Antibiotics, 11.10.3390/antibiotics11081010 ↗
39. Carvalho, M.F.N., Leite, S., Costa, J.P., Galvão, A.M., and Leitão, J.H. (2019). Ag(I) camphor complexes: Antimicrobial activity by design. J. Inorg. Biochem., 199.10.1016/j.jinorgbio.2019.110791 ↗
40. Cardoso, J.M.S., Guerreiro, S.I., Lourenço, A., Alves, M.M., Montemor, M.F., Mira, N.P., Leitão, J.H., and Carvalho, M.F.N.N. (2017). Ag(I) camphorimine complexes with antimicrobial activity towards clinically important bacteria and species of the Candida genus. PLoS ONE, 12.10.1371/journal.pone.0177355 ↗
41. Costa, J.P., Sousa, S.A., Galvão, A.M., Mata, J.M., Leitão, J.H., and Carvalho, M.F.N.N. (2021). Key Parameters on the Antibacterial Activity of Silver Camphor Complexes. Antibiotics, 10.10.3390/antibiotics10020135 ↗
42. Actinomycin D Identified as an Inhibitor of Discoidin Domain Receptor 2 Interaction with Collagen through an Insect Cell Based Screening of a Drug Compound Library10.1248/bpb.32.136 ↗
43. Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid10.4161/cbt.22274 ↗
44. Antibacterial activity of silver camphorimine coordination polymers10.1039/C6DT00099A ↗
45. Pinheiro, M.J.F., Costa, J.P., Marques, F., Mira, N.P., Carvalho, M.F.N.N., and Alves, M.M. (2021). Bioactive Coatings with Ag-Camphorimine Complexes to Prevent Surface Colonization by the Pathogenic Yeast Candida albicans. Antibiotics, 10.10.3390/antibiotics10060638 ↗
46. A review on the antimicrobial and antibiofilm activity of doped hydroxyapatite and its composites for biomedical applications10.1016/j.mtcomm.2022.103311 ↗
47. Simvastatin-hydroxyapatite coatings prevent biofilm formation and improve bone formation in implant-associated infections
48. Recent advances in hydroxyapatite/polymer/silver nanoparticles scaffolds with antimicrobial activity for bone regeneration10.1016/j.matlet.2023.134027 ↗
49. Effects of apatite particle size in two apatite/collagen composites on the osteogenic differentiation profile of osteoblastic cells10.3892/ijmm.2013.1516 ↗
50. MubarakAli, D., Arunachalam, K., Lakshmanan, M., Badar, B., Kim, J.-W., and Lee, S.-Y. (2023). Unveiling the Anti-Biofilm Properties of Hydroxyapatite on Pseudomonas aeruginosa: Synthesis and Strategy. Pharmaceutics, 15.10.3390/pharmaceutics15020463 ↗
51. Microbe Profile: Pseudomonas aeruginosa: Opportunistic pathogen and lab rat10.1099/mic.0.000860 ↗
52. Gnanamani, A., Periasamy, H., and Paul Satyaseela, M. (2017). Staphylococcus aureus: Overview of Bacteriology, Clinical Diseases, Epidemiology, Antibiotic Resistance and Therapeutic Approach. Frontiers in Staphylococcus aureus, IntechOpen Limited. Chapter 1.10.5772/67338 ↗
53. Peng, Q., Tang, X., Dong, W., Sun, N., and Yuan, W. (2023). A review of Biofilm Formation of Staphylococcus aureus and Its Regulation Mechanism. Antibiotics, 12.10.3390/antibiotics12010012 ↗
54. Tuon, F.F., Dantas, L.R., Suss, P.H., and Ribeiro, V.S.T. (2022). Pathogenesis of the Pseudomonas aeruginosa Biofilm: A review. Pathogens, 11.10.3390/pathogens11030300 ↗
55. The molecular mechanism of actinomycin D in preventing neointimal formation in rat carotid arteries after balloon injury10.1007/s11373-005-6900-5 ↗
56. Transition metal complexes of (1S,2S,3S)-3-hidroxy-camphorsultam10.1021/ic00075a036 ↗
57. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
58. Alves, L.G., Portel, J.F., Sousa, S.A., Ferreira, O., Almada, S., Silva, E.R., Martins, A.M., and Leitão, J.H. (2019). Investigations into the Structure/Antibacterial Activity Relationships of Cyclam and Cyclen Derivatives. Antibiotics, 8.10.3390/antibiotics8040224 ↗
59. Staphylococcal Coagulase: Mode of Action and Antigenicity